Humedix Co., Ltd.

KOSDAQ 200670.KQ

Humedix Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 15.06 M

Humedix Co., Ltd. Current Liabilities is USD 15.06 M for the year ending December 31, 2023, a -77.51% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Humedix Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 66.95 M, a 101.90% change year over year.
Humedix Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 33.16 M, a -1.40% change year over year.
Humedix Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 33.63 M, a 136.47% change year over year.
Humedix Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 14.22 M, a 11.77% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

KOSDAQ: 200670.KQ

Humedix Co., Ltd.

CEO	Jin-hwan Kim
IPO Date	Dec. 26, 2014
Location	South Korea
Headquarters	603, 268, Hagui-ro
Employees	226
Sector	Consumers Staples
Industries Personal Care Biotechnology Cosmetics Dental Care Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Pharmaceuticals

Description

Humedix Co., Ltd., a healthcare company, researches, develops, manufactures, and sells various pharmaceutical products in South Korea. It offers over-the-counter drugs, prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic products, and functional synthetic materials, as well as health functional foods. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.

Key trends

Past 5 years